Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So entertaining like how the last three stocks you've been in went down 99,99 & 60% so that means this one will?
LMFAO
Can I get you to guarantee ELI-200 doesn't get approved?
Wow, you forget the Epic acquisition which was one of the largest in Q1. Doh!
Great post, thank you!
Correct, only the ADT ELTP products deter abuse. The profitable generics aren't ADT. Great catch!
So a 10% swing is a tight range? How large does the % have to go before charts are applicable?
Plus your quote range was .03 instead of .01.
So your saying charts are useless in determining when a stock will trade outside the range? Which is it?
So charts don't apply now but will in the future? Got it!
There was perfect clarity in my response. Supply & Demand. Not sure why this is so difficult?
Can anyone else here help him out? I'm not a teacher so maybe that's the problem...
No theory, just simple economics. Supply and demand.
Duh, there's no money in a cure.
BostonTrader said charts don't matter so who's right?
http://www.pharmexec.com/pharma-blamed-driving-opioid-abuse-epidemic
"FDA has approved approximately 35 extended-release/long-acting (ER/LA) therapies and five ER products with abuse deterrent features, but these medications are expensive and comprise only 10% of the market. About 90% of opioid prescribing is for some 175 immediate-release (IR) products, including more than 100 generics. One response is to encourage the development of less costly generic versions of long-acting ADFs, as well as and new non-opioid compounds able to manage pain more safely and economically."
States with legislation to make ADF's more readily available and covered by insurance:
http://sppan.aapainmanage.org/abusedeterrent
Map is at the bottom.
I highly suggest everyone read this:
https://www.alec.org/app/uploads/2016/01/2016-ALEC-State-Factor-Optimizing-the-Abuse-deterrent-Opioids-Market-Final.pdf
I love this post, should be a sticky!!!
namtae Member Level Monday, 04/25/16 02:24:26 PM
Re: julesnemo3 post# 196521
Post #
196524
of 197501 Go
Quote:
Continuing to hold a Short against a small pharmaceutical company (ELTP)
You forgot one thing, ELTP has an outrageous market cap of appx $300M!! Lots of downside for shorts to enjoy!!
They are buying ELTP with a fistful of Yen!!!
https://twitter.com/hashtag/namtae
In the spirit of "spinning" I'll pile on to your fact based post:
http://www.pfizer.com/news/press-release/press-release-detail/pfizer_announces_fda_acceptance_for_review_of_a_new_drug_application_for_alo_02_oxycodone_hydrochloride_and_naltrexone_hydrochloride
http://www.fda.gov/AdvisoryCommittees/Calendar/ucm491171.htm
As you are aware, and shorts ignore, is the fact that the stream of news prior to ELI-200 approval has a material impact on the pipeline going forward.
There's two other examples of this including one next week. Knowledge is power.
In the spirit of "spinning" I'll pile on to your fact based post:
http://www.pfizer.com/news/press-release/press-release-detail/pfizer_announces_fda_acceptance_for_review_of_a_new_drug_application_for_alo_02_oxycodone_hydrochloride_and_naltrexone_hydrochloride
http://www.fda.gov/AdvisoryCommittees/Calendar/ucm491171.htm
As you are aware, and shorts ignore, is the fact that the stream of news prior to ELI-200 approval has a material impact on the pipeline going forward.
There's two other examples of this including one next week. Knowledge is power.
What site do savvy investors use or do they stick to the script?
Locked and loaded for next week. With these candles I'm surprised anyone would try and go short here.
http://www.stockta.com/cgi-bin/analysis.pl?symb=ELTP&cobrand=&mode=stock
Recent CandleStick Analysis
Very Bullish
Date Candle
Apr-29-2016 Bullish Engulfing
Apr-28-2016 Homing Pigeon
Apr-27-2016 Homing Pigeon
Apr-26-2016 Homing Pigeon
Apr-25-2016 DOJI
Please share what we don't know. For instance, I didn't know that legitimate stocks didn't trade up to the closing bell like Elite does. Hence the reason for those trades you call "paint tape".
Wow, you've certainly done your research. No important news next week huh?
My absolute favorite is the comment about the market cap being 300m when an amateur can look it up as around 230m. Then they say it's because of mysterious dilution. Less they forget that dilution imply a drop in the PPS and has no bearing on market cap.
Yawn... Here we go again. First the approval is baked in and then the market cap is 400m on approval.
So what else is priced in that we don't know about?
So if a stock in the mid .40's crashes to the mid .20's, what do you call a rise from .325 to .50? A minor bump?
You see, the opposite of a stock crashing is.....
Here's the link to the outrageous 300m market cap:
"You forgot one thing, ELTP has an outrageous market cap of appx $300M!! Lots of downside for shorts to enjoy!!"
Who prices in the addition of a board member to a stock? Like anyone outside of the company knew he would be added...
A move from .325 to .50 is hardly a small bump, certainly doesn't support a baked in approval either. Didn't you also say the market cap was currently 300m and that we'd see the light upon the 10K dropping?
If you are going to chastise those with high ambitions you shouldn't be surprised when those with low ambitions have the favor returned.
Yeah, we'll be talking about the days slumming on the message boards when the stock was at .30 while drinking champagne on my new yacht.
I love it, a pharmaceutical company spends 14.56 TTM on research & development. I suppose you'd prefer a biotech that doesn't invest in R&D? NH has prove he's developing the pipeline and I don't think he's spending enough.
How did you miss the mark on the 60% assignment? And why couldn't you close the deal leaving 1% on the table?
Please provide the "Bright Future Index Score". I'd love to compare against other stocks with a bright future.
Here we go with the ANDA's again... And the mystery dilution continues to rear it's ugly head. Elite is sitting on an excess of 8 million in cash (As of 12/15) and this guy seems to think Elite is forced to issue more shares. Were they forced to issue more shares before or after the 5 million dollar milestone payment on ELI-200 from Epic?
Here we go with the ANDA's again... And the mystery dilution continues to rear it's ugly head. Elite is sitting on an excess of 8 million in cash (As of 12/15) and this guy seems to think Elite is forced to issue more shares. Were they forced to issue more shares before or after the 5 million dollar milestone payment on ELI-200 from Epic?
I almost look forward to no news so that the board gets to witness your tantrums.
Deals, as in job assignments?